On the other hand, also in breast cancer, antioxidant treatment decreased DNA lesions and tumorigenesis in a murine model of BRCA1-deficient, p53+/− breast cancer, where excessive estrogen metabolism increased cancer cell ROS production and DNA damage (48). This evidence concerns the gene BRCA1 and breast cancer.